These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32209730)

  • 1. Expression and prognosis analysis of
    Zhang T; Zhao Y; Zhao Y; Zhou J
    Aging (Albany NY); 2020 Mar; 12(6):5031-5047. PubMed ID: 32209730
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
    Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
    Zhao Y; Zhang T; Zhao Y; Zhou J
    Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognosis analysis of
    Zhang TJ; Zhang LC; Xu ZJ; Zhou JD
    Aging (Albany NY); 2020 Jun; 12(14):14677-14690. PubMed ID: 32597790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TET enzymes are successively expressed during human spermatogenesis and their expression level is pivotal for male fertility.
    Ni K; Dansranjavin T; Rogenhofer N; Oeztuerk N; Deuker J; Bergmann M; Schuppe HC; Wagenlehner F; Weidner W; Steger K; Schagdarsurengin U
    Hum Reprod; 2016 Jul; 31(7):1411-24. PubMed ID: 27141042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of ten-eleven translocation genes in endometrial cancers.
    Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
    Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer.
    Yang L; Yu SJ; Hong Q; Yang Y; Shao ZM
    PLoS One; 2015; 10(7):e0133896. PubMed ID: 26207381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.
    Gaidzik VI; Paschka P; Späth D; Habdank M; Köhne CH; Germing U; von Lilienfeld-Toal M; Held G; Horst HA; Haase D; Bentz M; Götze K; Döhner H; Schlenk RF; Bullinger L; Döhner K
    J Clin Oncol; 2012 Apr; 30(12):1350-7. PubMed ID: 22430270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
    J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes.
    Laukka T; Mariani CJ; Ihantola T; Cao JZ; Hokkanen J; Kaelin WG; Godley LA; Koivunen P
    J Biol Chem; 2016 Feb; 291(8):4256-65. PubMed ID: 26703470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia.
    Nabil R; Hassan NM; Abdellateif MS; Gawdat RM; Elshazly SS
    Mol Biol Rep; 2023 Jan; 50(1):641-653. PubMed ID: 36371552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced mRNA and Protein Expression Levels of Tet Methylcytosine Dioxygenase 3 in Endothelial Progenitor Cells of Patients of Type 2 Diabetes With Peripheral Artery Disease.
    Zhao S; Jia T; Tang Y; Zhang X; Mao H; Tian X; Li R; Ma L; Chen G
    Front Immunol; 2018; 9():2859. PubMed ID: 30574144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Li XX; Guo H; Wen XM; Zhang W; Yang L; Liu XH; Lin J; Qian J
    Diagn Pathol; 2019 Jun; 14(1):68. PubMed ID: 31253168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
    Wang R; Gao X; Yu L
    BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
    Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
    Ohgami RS; Ma L; Merker JD; Gotlib JR; Schrijver I; Zehnder JL; Arber DA
    Mod Pathol; 2015 May; 28(5):706-14. PubMed ID: 25412851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.
    Abdel-Wahab O; Mullally A; Hedvat C; Garcia-Manero G; Patel J; Wadleigh M; Malinge S; Yao J; Kilpivaara O; Bhat R; Huberman K; Thomas S; Dolgalev I; Heguy A; Paietta E; Le Beau MM; Beran M; Tallman MS; Ebert BL; Kantarjian HM; Stone RM; Gilliland DG; Crispino JD; Levine RL
    Blood; 2009 Jul; 114(1):144-7. PubMed ID: 19420352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutations.
    Zhou L; An J; Hou C; Ding Z; Qiu H; Tang X; Sun A; Chen S; Xu Y; Liu T; Wu D
    Hematology; 2021 Dec; 26(1):340-347. PubMed ID: 33840380
    [No Abstract]   [Full Text] [Related]  

  • 19. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
    Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
    J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
    Van Damme M; Crompot E; Meuleman N; Maerevoet M; Mineur P; Bron D; Lagneaux L; Stamatopoulos B
    Clin Epigenetics; 2016; 8():132. PubMed ID: 27980696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.